Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biotech Start-Up Sequential Skin Raises Funds - Beauty Packaging

What are you searching for?

Sign in
Beauty Industry

Biotech Start-Up Sequential Skin Raises Funds

The company will develop new tools for brands using its novel patch-based, skin analysis technology—and plans to develop a consumer product.

Author Image

By: Marie Redding

Senior Editor, Rodman Media


Biotech start-up Sequential Skin has raised $1.65M in an oversubscribed seed round. The company, which is based in the UK and Singapore, focuses on skin health and skin microbiome technology.

The round was led by Metaplanet, and supported by Scrum Ventures, SOSV, Genedant, and angel investor, Ben Holmes. 

This latest investment brings the total venture funding raised by Sequential Skin to $2.15M in 2021.

The investment will be used to extend their B2B offering to skincare, haircare and healthcare companies, adding to the twelve major clients currently using Sequential Skin.

The company also plans to roll out its consumer product, with a focus on expanding into the U.S. via New York City.

“The world of skincare is flooded with a confusing array of products that only help some of the people, some of the time,” said Rauno Miljand, Metaplanet Managing Partner. “We’re proud to lead the investment in Sequential Skin. It is the first company, using genomics and microbiome skin assays, that identifies to consumers the exact products suited for each individual.”

 Dr Oliver Worsley, CEO and cofounder, says, “We now have significant traction in assembling an extensive dataset on skin types from Asia, Europe and the U.S.—a great chance for us to discover novel biomarkers for skin conditions in different populations,” said Dr Oliver Worsley, CEO and cofounder.

The funding will significantly boost the company’s IP portfolio, using their novel patch-based, skin analysis, to develop further tools to understand how your genetics, epigenetics and skin microbiome, affect health and disease.

Dr Albert Dashi, CSO and cofounder, added: “Our scope is to provide science to people and empower them with the right tools and knowledge so they make the right decision for the future of their skin health and well-being.”

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Add Beauty Packaging as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters

Topics